logo-loader
viewEnzychem Lifesciences

Enzychem Lifesciences advancing its therapy derived from deer antlers

Enzychem Lifesciences Corp (KOSDAQ:183490) CEO Ki Young Sohn sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The South Korea and New Jersey-based biopharma company's lead compound is an immune resolution accelerator that is derived from deer antlers, with the potential to be used for a variety of indications.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks finish week in the red; Canaccord initiates...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was down 2.6% higher at 117.4 points. Elsewhere, the OTCQX Cannabis index fell 1.8% to 480.1 points. Buds today were Pharmacielo Ltd (CVE:PCLO), The Valens Company (CVE:VLNS) (OTCMKTS:VLNCF)....

1 day, 3 hours ago

2 min read